Hi Tech Quote - HITK | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Hi-Tech Pharmacal Co., Inc. (MM) (HITK) Share Price

Hi-Tech Pharmacal Co., Inc. (MM) (HITK)

43.49

0.00

(0.00%)

Closed March 13 3:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

43.49

Bid

0.00

Ask

0.00

Volume

-

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

43.49

Open

-

Last Trade

Last Trade Time

Average Volume (3m)

-

Financial Volume

-

VWAP

-

Keller Rohrback L.L.P. Announces Investigation Regarding Weight-Loss & Workout Supplements Containing Potentially Dangerous A...

Attorney Advertising. Keller Rohrback L.L.P. is currently investigating recent reports that several brands of supplements contain BMPEA...

Akorn Completes Acquisition of Hi-Tech Pharmacal

Akorn, Inc. (NASDAQ: AKRX), a niche pharmaceutical company, announced today that it has completed its previously announced acquisition of...

Repligen Corporation Set to Join the S&P SmallCap 600

Repligen Corporation Set to Join the S&P SmallCap 600 PR Newswire NEW YORK, April 15, 2014 NEW YORK, April 15, 2014 /PRNewswire/ -- Repligen...

Akorn Receives FTC Clearance for Hi-Tech Pharmacal Acquisition

Akorn, Inc. (NASDAQ: AKRX) today announced that the U.S. Federal Trade Commission (FTC) has voted to approve Akorn’s acquisition of Hi-Tech...

Hi-Tech Pharmacal Reports Sales of $59.9 Million for the Third Quarter Ended January 31, 2014

Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) today reported results for the third fiscal quarter ended January 31, 2014. Net sales of...

Hi-Tech Pharmacal Receives Final Approval for Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day)

Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK), a specialty pharmaceuticals company, announced today that the US Food and Drug Administration...

Hi-Tech Pharmacal Announces Settlement Regarding Texas Pricing Investigation

Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) today announced that the Texas Attorney General has agreed to close its investigation of Hi-Tech’s...

Hi-Tech Pharmacal Reports Sales of $58.6 million for the Second Quarter Ended October 31, 2013

Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) today reported results for the second fiscal quarter ended October 31, 2013. Net sales of...

AQR Capital Management 3Q 13F: Largest Purchases -2-

TAKE TWO INTERACTIVE SOFTWARE $4,686,952 257,950 212,607 POLYCOM INC COM $29,382,237 2,690,681 206,953 BLACKROCK CREDIT ALLOCATION IN...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

HITK - Frequently Asked Questions (FAQ)

What is the current Hi Tech share price?

The current share price of Hi Tech is US$ 43.49

What is the 1 year trading range for Hi Tech share price?

Hi Tech has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RGCRegencell Bioscience Holdings Ltd	US$ 14.25 (239.29%)	23.33M
LZMHLZ Technology Holdings Ltd	US$ 13.29 (62.47%)	860.76k
HMRHeidmar Maritime Holdings Corporation	US$ 4.08 (60.00%)	84.65M
ICONIcon Energy Corporation	US$ 0.1356 (45.65%)	85.57M
AVAHAveanna Healthcare Holdings Inc	US$ 5.15 (37.70%)	3.4M
CMCTCreative Media and Community Trust Corporation	US$ 0.35 (-46.15%)	2.1M
SPHLSpringview Holdings Ltd	US$ 0.7194 (-41.98%)	2.7M
ADTXAditxt Inc	US$ 0.0339 (-40.32%)	118.87M
ULYUrgent ly Inc	US$ 0.3086 (-39.44%)	1.76M
PSTVPlus Therapeutics Inc	US$ 0.7501 (-38.01%)	3.89M
SPGCSacks Parente Golf Inc	US$ 0.1388 (28.52%)	365.79M
NVDANVIDIA Corporation	US$ 115.58 (-0.14%)	298.57M
INTCIntel Corporation	US$ 23.70 (14.60%)	243.25M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 8.585 (-6.07%)	217.49M
TQQQProShares UltraPro QQQ	US$ 57.79 (-5.46%)	121.22M

TheFinalCD

TheFinalCD 11 years ago

HITK pays $25M fine to TX

Penny Roger$

Penny Roger$ 13 years ago

~ Friday! $HITK ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $HITK ~ Earnings expected on Friday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.

http://stockcharts.com/h-sc/ui?s=HITK&p=D&b=3&g=0&id=p88783918276&a=237480049

http://stockcharts.com/h-sc/ui?s=HITK&p=W&b=3&g=0&id=p54550695994

~ Google Finance: http://www.google.com/finance?q=HITK
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=HITK#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=HITK+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=HITK
Finviz: http://finviz.com/quote.ashx?t=HITK
~ BusyStock: http://busystock.com/i.php?s=HITK&v=2

<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=HITK >>>>>>

http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

BiotechInvestor90210

BiotechInvestor90210 14 years ago

Hello there friend. I was never bashing the stock, just losing Lodrane was a hit. HITK is an amazing stock!

dealerschool2006

dealerschool2006 14 years ago

since your post HITK has gained almost 50% and now a little less than 30%...

BiotechInvestor90210

BiotechInvestor90210 14 years ago

This is bad news for Hi-Tech...

BiotechInvestor90210

BiotechInvestor90210 14 years ago

This is bad news for Hi-Tech...

BiotechInvestor90210

BiotechInvestor90210 14 years ago

This is bad news for Hi-Tech...

BNP Paribas Issuance

Australia and New Zealan...

Tectonic Financial

NZDM25 - Junho 2025

BNP Paribas Issuance

Commonwealth Bank of Aus...

Viking Gold Exploration

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions